TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 21 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2014 | $1,041,000 | – | 100,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,547,248 | $3,729,000 | 0.20% |
| Broadfin Capital, LLC | 825,986 | $1,991,000 | 0.19% |
| PURA VIDA INVESTMENTS, LLC | 159,877 | $385,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,315,551 | $3,170,000 | 0.14% |
| FT Options LLC | 50,600 | $122,000 | 0.13% |
| Lombard Odier Asset Management (USA) Corp | 231,974 | $559,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 385,248 | $928,000 | 0.05% |
| Integre Asset Management, LLC | 57,501 | $139,000 | 0.04% |
| BLUESTEIN R H & CO LLC | 185,975 | $448,000 | 0.03% |
| Alambic Investment Management, L.P. | 33,880 | $82,000 | 0.03% |